Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 1, 2005
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
Raymond Wong, Munir Shahjahan, Xuemei Wang, et al.
Haematologica
|
June 29, 2014
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
Dominik Dytfeld, Jagoda Jasielec, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas
Issa F Khouri, Rima M Saliba, Chitra Hosing, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report
Kirk R Schultz, David B Miklos, Daniel Fowler, et al.
Blood
|
April 16, 2008
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F Khouri, Peter McLaughlin, Rima M Saliba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
Simrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2005
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
Alexandra H Filipovich, Daniel Weisdorf, Steven Pavletic, et al.
Haematologica
|
August 5, 2018
Upper gastrointestinal acute graft-<i>versus</i>-host disease adds minimal prognostic value in isolation or with other graft-<i>versus</i>-host disease symptoms as currently diagnosed and treated
Sarah Nikiforow, Tao Wang, Michael Hemmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2020
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Ayman Saad, Marcos de Lima, Sarah Anand, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 1, 2005
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
Raymond Wong, Munir Shahjahan, Xuemei Wang, et al.
Haematologica
|
June 29, 2014
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
Dominik Dytfeld, Jagoda Jasielec, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas
Issa F Khouri, Rima M Saliba, Chitra Hosing, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report
Kirk R Schultz, David B Miklos, Daniel Fowler, et al.
Blood
|
April 16, 2008
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F Khouri, Peter McLaughlin, Rima M Saliba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
Simrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2005
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
Alexandra H Filipovich, Daniel Weisdorf, Steven Pavletic, et al.
Haematologica
|
August 5, 2018
Upper gastrointestinal acute graft-<i>versus</i>-host disease adds minimal prognostic value in isolation or with other graft-<i>versus</i>-host disease symptoms as currently diagnosed and treated
Sarah Nikiforow, Tao Wang, Michael Hemmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2020
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Ayman Saad, Marcos de Lima, Sarah Anand, et al.
Page
of 8